UCLA Health experts advise on how we can protect ourselves from COVID-19
University of California, Los Angeles (UCLA), Health Sciences
Un grupo de investigadores de la Universidad de California Los Ángeles (UCLA), ha desarrollado una aplicación web que permite a todo el mundo ayudar en la lucha contra el coronavirus.
UCLA researchers identify a possible new drug that could help prevent cognitive decline in people who undergo radiation therapy for brain tumors.
UCLA has joined a nationwide effort to study whether convalescent plasma collected from people who have recovered from COVID-19 may yield a treatment for the deadly virus.
n the years after 2014, when the Affordable Care Act’s health insurance marketplaces were established, low-income patients who underwent a surgical procedure saved an average of $601 in out-of-pocket spending and $968 in premium spending per year, compared to before the marketplaces existed. Those low-income patients also had a 35% lower chance of having catastrophic levels of household medical spending. However, for middle-income patients, spending levels were about the same before and after the marketplaces began.
A new national registry has been launched by specialists in obstetrics, gynecology and reproductive sciences at UCLA Health and the University of California, San Francisco, to determine COVID-19’s possible effects on pregnant women and newborns.
UCLA researchers have launched an app called Stop COVID-19 Together, which is designed to predict the spread of COVID-19 throughout the community and to assess the effectiveness of current measures in that community, including physical distancing. The app will build a map of possible hotspots where there may be a higher risk for accelerated spread of the disease.
UCLA Health is one of 75 sites around the globe participating in a clinical trial sponsored by the National Institutes of Health to test the effectiveness of a candidate anti-viral drug against COVID-19.
Live video telehealth services are a critical component of the COVID-19 response. Offered by physicians, other clinicians and health-care organizations, telehealth provides a useful method for starting and continuing essential mental health treatment without risk of spreading infection.
To stop the spread of the COVID-19 coronavirus, the governing bodies of cities and states across the country are ordering people to stay home. But studies have shown that the loneliness and depression that may result from social isolation impacts not only mental health, but physical health as well. Jena Lee, MD, a board-certified child and adult psychiatrist and clinical instructor at the David Geffen School of Medicine at UCLA, discussed how stay-at-home and shelter-in-place orders may affect emotional and physical wellbeing, and how to counteract those effects.
Ziva Cooper, research director of the UCLA Cannabis Research Initiative, has been awarded a $3.9 million grant from the National Center for Complementary and Integrative Health at the NIH to study whether cannabis chemicals called terpenes can reduce the amount of opioid medication a person needs to reduce pain.
UCLA Oncologists Gary Schiller, MD, and Joshua Sasine, MD, PhD, help explain what cancer patients need to know about COVID-19.
Jim James enrolled in a UCLA Health clinical trial to treat melanoma that spread in his lungs and liver. Today, most of the tumors have diminished in size by at least 50% and there’s no trace of any new tumors.
In advance of International Women’s Day (Sunday, March 8), new research from the WORLD Policy Analysis Center at the UCLA Fielding School of Public Health (WORLD) shows that in countries where gender parity is high, both men and women live longer than in countries where equality is low.
Breathing propels everything we do—so its rhythm must be carefully organized by our brain cells, right? Wrong. Every breath we take arises from a disorderly group of neurons – each like a soloist belting out its song before uniting as a chorus to harmonize on a brand-new melody. Or, in this case, a fresh breath.
Study examines the role of small molecule in children with a rare liver disease
A molecule identified by UCLA researchers helps maintain a healthy balance of cells in airway and lung tissue. If the compound, so far only studied in isolated human and mouse cells, has the same effect in people, it may lead to new drugs to treat or prevent lung cancer.
UCLA researchers have found that it is possible to assess a person’s ability to feel empathy by studying their brain activity while they are resting rather than while they are engaged in specific tasks.
In 1988, a 6.9 magnitude earthquake struck near the northern Armenian city of Spitak. The temblor destroyed cities and is estimated to have killed between 25,000 and 35,000 people, many of whom were schoolchildren.
The emotional distress that often accompanies a breakup is called social pain, and it may cause sadness, depression and loneliness, as well as actual physical pain, research has shown. A study, published recently in the Annals of Behavioral Medicine may have found an antidote – forgiveness combined with acetaminophen, the active ingredient in Tylenol.
A new study led by researchers UCLA found that treating soft tissue sarcoma with radiation over a significantly shorter period of time is safe, and likely just as effective, as a much longer conventional course of treatment.
A UCLA-led study reveals a new role for a gene that’s associated with autism spectrum disorder, intellectual disability and language impairment.
In a UCLA-led phase I clinical trial, a new plant-based drug called APG-157 showed signs of helping patients fight oral and oropharyngeal cancers. These cancers are located in the head and the neck. APG-157 is made up of multiple compounds produced by plants, including curcumin. UCLA Jonsson Comprehensive Cancer Center researchers found that treatment with this botanical drug resulted in high concentrations of curcumin and its byproducts circulating in the blood and absorbed by tumor tissues within three hours after being taken orally.
An interdisciplinary team of researchers at the UCLA Jonsson Comprehensive Cancer Center has developed a medicated patch that can deliver immune checkpoint inhibitors and cold plasma directly to tumors to help boost the immune response and kill cancer cells.
A UCLA-led study has found that levels of six proteins in the blood can be used to gauge a person’s risk for cerebral small vessel disease, or CSVD, a brain disease that affects an estimated 11 million older adults in the U.S.
Using an immunotherapy drug in combination with an infusion of anti-tumor immune cells may produce a stronger immune response that could help fight advanced melanoma.
An $18 million commitment from the Simms/Mann Family Foundation will support UCLA’s expansion of integrative psychosocial care for people with cancer and their families into communities throughout Southern California.
The study reveals a detailed epigenetic mechanism for how interleukin-1-beta, a common cytokine that helps fight infections during inflammation, plays a critical role in cancer metastasis.
UCLA researchers are part of an international team that reported the use of a stem cell gene therapy to treat nine people with the rare, inherited blood disease known as X-linked chronic granulomatous disease, or X-CGD. Six of those patients are now in remission and have stopped other treatments. Before now, people with X-CGD – which causes recurrent infections, prolonged hospitalizations for treatment, and a shortened lifespan – had to rely on bone marrow donations for a chance at remission.
Rhinoplasty may make a woman appear to be three years younger, machine learning shows
A new study finds that an interactive voice application using artificial intelligence is as accurate at tracking the wellbeing of patients being treated for serious mental illness as their physicians.
In a UCLA-led study, children and adolescents with a high risk for developing bipolar disorder stayed healthier for longer periods when their family members participated in their psychotherapy sessions.